Corrigendum to: Candidate locus analysis for PHACE syndrome (American Journal of Medical Genetics Part A, (2012), 158A, 6, (1363-1367), 10.1002/ajmg.a.35341);Candidate locus analysis for PHACE syndrome

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 6, 2012, Pages 1363-1367

  Mitchell, Sheri ^a   Siegel, Dawn H ^b   Shieh, Joseph T C ^c   Stevenson, David A ^d   Grimmer, J Fredrik ^d   Lewis, Tracey ^a   Metry, Denise ^e   Frieden, Ilona ^c   Blei, Francine ^f   Kayserili, Hulya ^g   Drolet, Beth A ^b   Bayrak Toydemir, Pinar ^a,d  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f Vascular Birthmark Institute of New York   (United States)

^g ISTANBUL UNIVERSITY   (Turkey)

Author keywords

AKR1B1; Chromosome region 7q33; Deletion; Microarray; PHACE syndrome; SLC35B4

Indexed keywords

ADULT; AKR1B1 GENE; ARTICLE; AUTOSOME; CHROMOSOME 7Q33; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COPY NUMBER VARIATION; DYSPLASTIC NEVUS; EYE EXAMINATION; FEMALE; GENE; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HAPLOTYPE; HUMAN; INFANT; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PHACE SYNDROME; PHAKOMATOSIS; PRIORITY JOURNAL; SCLERODERMA; SKIN HEMANGIOMA; SLC35B4 GENE;

EID: 84861224880     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.62621     Document Type: Erratum

References (19)

1. Ashikov A, Routier F, Fuhlrott J, Helmus Y, Wild M, Gerardy-Schahn R, Bakker H. 2005. The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine. J Biol Chem 280: 27230- 27235.
2. Drolet BA, Pope E, Juern AM, Sato T, Howell B, Puttgen KB, Lara-Corrales I, Gilliam A, Mancini A, Powell J, Siegel D, Metry D, Stevenson DA, Grimmer F, Frieden IJ. 2011. Gastointestinal bleeding in infantile hemangioma: A complication of segmental, rather than multifocal infantile hemangiomas. J Pediatr [accepted with minor revisions].
3. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446- 450.
4. Frieden IJ, Reese V, Cohen D. 1996. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 132: 307- 311.
5. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR, Giardine BM, Harte RA, Hillman-Jackson J, Hsu F, Kirkup V, Kuhn RM, Learned K, Li CH, Meyer LR, Pohl A, Raney BJ, Rosenbloom KR, Smith KE, Haussler D, Kent WJ. 2011. The UCSC Genome Browser database: Update 2011. Nucleic Acids Res 39: D876- D882.
6. Girirajan S, Eichler EE. 2010. Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19: R176- R187.
7. Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, Vives L, Walsh T, McCarthy SE, Baker C, Mefford HC, Kidd JM, Browning SR, Browning BL, Dickel DE, Levy DL, Ballif BC, Platky K, Farber DM, Gowans GC, Wetherbee JJ, Asamoah A, Weaver DD, Mark PR, Dickerson J, Garg BP, Ellingwood SA, Smith R, Banks VC, Smith W, McDonald MT, Hoo JJ, French BN, Hudson C, Johnson JP, Ozmore JR, Moeschler JB, Surti U, Escobar LF, El-Khechen D, Gorski JL, Kussmann J, Salbert B, Lacassie Y, Biser A, McDonald-McGinn DM, Zackai EH, Deardorff MA, Shaikh TH, Haan E, Friend KL, Fichera M, Romano C, Gecz J, DeLisi LE, Sebat J, King MC, Shaffer LG, Eichler EE. 2010. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42: 203- 209.
8. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ. 2006. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 118: 882- 887.
9. Haggstrom AN, Garzon MC, Baselga E, Chamlin SL, Frieden IJ, Holland K, Maguiness S, Mancini AJ, McCuaig C, Metry DW, Morel K, Powell J, Perkins SM, Siegel D, Drolet BA. 2010. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 126: e418- e426.
10. Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P, Adams D, Siegel D, Hall K, Powell J, Frieden I, Drolet B. 2009a. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124: 1447- 1456.
11. Metry DW, Garzon MC, Drolet BA, Frommelt P, Haggstrom A, Hall J, Hess CP, Heyer GL, Siegel D, Baselga E, Katowitz W, Levy ML, Mancini A, Maronn ML, Phung T, Pope E, Sun G, Frieden IJ. 2009b. PHACE syndrome: Current knowledge, future directions. Pediatr Dermatol 26: 381- 398.
12. Pascual-Castroviejo I. 1978. Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas. Neuroradiology 16: 82- 84.
13. So WY, Wang Y, Ng MC, Yang X, Ma RC, Lam V, Kong AP, Tong PC, Chan JC. 2008. Aldose reductase genotypes and cardiorenal complications: An 8-year prospective analysis of 1, 074 type 2 diabetic patients. Diabetes Care 31: 2148- 2153.
14. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465- 4470.
15. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101: 6062- 6067.
16. Thamotharampillai K, Chan AK, Bennetts B, Craig ME, Cusumano J, Silink M, Oates PJ, Donaghue KC. 2006. Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms. Diabetes Care 29: 2053- 2057.
17. Wolford JK, Yeatts KA, Red Eagle AR, Nelson RG, Knowler WC, Hanson RL. 2006. Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians. Diabetes Med 23: 367- 376.
18. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW III, Su AI. 2009. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
19. Xu M, Chen X, Yan L, Cheng H, Chen W. 2008. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: A meta-analysis. J Mol Endocrinol 40: 243- 251.